GSK

G500-2020-282-GlaxoSmithKline
Simon Dawson—Bloomberg/Getty Images

Company Information

As of 8/3/2022
Country
Britain
Headquarters
Brentford, Britain
Industry
Pharmaceuticals
CEO
Emma N. Walmsley
Company Type
Public
Ticker
GSK
Revenues ($M)
$46,915
Profits ($M)
$6,030
Market Value ($M)
$87,095
Employees
90,096
Figures prepared in accordance with International Accounting Standards. Changed name from GlaxoSmithKline, May 16, 2022. Market value as of July 19, 2022.

Key Financials (Last Fiscal Year)

($ Millions)
% change
Revenues ($M)
$46,914.8
7.3%
Profits ($M)
$6,030.4
-18.2%
Assets ($M)
$107,129.2
-
Total Stockholder Equity ($M)
$20,389
-

Profit Ratios

Profit as % of Revenues
12.9%
Profits as % of Assets
5.6%
Profits as % of Stockholder Equity
29.6%
Lists ranking GSK
RANK294
Global 500 - 2022Aggregate sales hit $37.8 trillion last year—an in...READ MORE